2031.20 -20.60 (-1.00%)

691.7K NSE+BSE Volume

NSE 17 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Observation
Lupin receives Form 483 with six observations from the US FDA for its Nagpur injectable facility See details


Lupin Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LUPIN, BSE:500257 Lupin Ltd.

923 Votes:
Buy 72.81%
Sell 17.44%
Hold 9.75%
BUY
SELL
HOLD
All reports of LUPIN